Are Human Dental Papilla-derived Stem Cell and Human Brain-derived Neural Stem Cell Transplantations Suitable for Treatment of Parkinson's Disease?

Overview

Journal Neural Regen Res

Date 2014 Sep 11

PMID 25206413

Citations 7

Authors

Hyung Ho Yoon

Joongkee Min

Nari Shin

Yong Hwan Kim

Jin-Mo Kim

Yu-Shik Hwang

Jun-Kyo Francis Suh

Onyou Hwang

Sang Ryong Jeon

Affiliations

Soon will be listed here.

Abstract

Transplantation of neural stem cells has been reported as a possible approach for replacing impaired dopaminergic neurons. In this study, we tested the efficacy of early-stage human dental papilla-derived stem cells and human brain-derived neural stem cells in rat models of 6-hydroxydopamine-induced Parkinson's disease. Rats received a unilateral injection of 6-hydroxydopamine into right medial forebrain bundle, followed 3 weeks later by injections of PBS, early-stage human dental papilla-derived stem cells, or human brain-derived neural stem cells into the ipsilateral striatum. All of the rats in the human dental papilla-derived stem cell group died from tumor formation at around 2 weeks following cell transplantation. Postmortem examinations revealed homogeneous malignant tumors in the striatum of the human dental papilla-derived stem cell group. Stepping tests revealed that human brain-derived neural stem cell transplantation did not improve motor dysfunction. In apomorphine-induced rotation tests, neither the human brain-derived neural stem cell group nor the control groups (PBS injection) demonstrated significant changes. Glucose metabolism in the lesioned side of striatum was reduced by human brain-derived neural stem cell transplantation. [(18)F]-FP-CIT PET scans in the striatum did not demonstrate a significant increase in the human brain-derived neural stem cell group. Tyrosine hydroxylase (dopaminergic neuronal marker) staining and G protein-activated inward rectifier potassium channel 2 (A9 dopaminergic neuronal marker) were positive in the lesioned side of striatum in the human brain-derived neural stem cell group. The use of early-stage human dental papilla-derived stem cells confirmed its tendency to form tumors. Human brain-derived neural stem cells could be partially differentiated into dopaminergic neurons, but they did not secrete dopamine.

Citing Articles

Investigating the Therapeutics Effects of Oral Cavity Derived Stem Cells on Neurodegenerative Diseases: A Systematic Review.

Uzunoglu-Ozyurek E, Onal G, Dokmeci S Basic Clin Neurosci. 2024; 14(5):565-584.

PMID: 38628839 PMC: 11016878. DOI: 10.32598/bcn.2021.2892.1.

Transplantation of human neural stem cell prevents symptomatic motor behavior disability in a rat model of Parkinson's disease.

Wang F, Cheng X, Zhang Y, Bai Q, Zhang X, Sun X Open Life Sci. 2024; 19(1):20220834.

PMID: 38465343 PMC: 10921471. DOI: 10.1515/biol-2022-0834.

Neural stem cells for Parkinson's disease management: Challenges, nanobased support, and prospects.

Oz T, Kaushik A, Kujawska M World J Stem Cells. 2023; 15(7):687-700.

PMID: 37545757 PMC: 10401423. DOI: 10.4252/wjsc.v15.i7.687.

Current Status and Future Strategies to Treat Spinal Cord Injury with Adult Stem Cells.

Jeong S, Choi I, Jeon S J Korean Neurosurg Soc. 2019; 63(2):153-162.

PMID: 31805758 PMC: 7054109. DOI: 10.3340/jkns.2019.0146.

Taking a bite out of spinal cord injury: do dental stem cells have the teeth for it?.

Bianco J, De Berdt P, Deumens R, des Rieux A Cell Mol Life Sci. 2016; 73(7):1413-37.

PMID: 26768693 PMC: 11108394. DOI: 10.1007/s00018-015-2126-5.

References

Lei Z, Jiang Y, Li T, Zhu J, Zeng S . Signaling of glial cell line-derived neurotrophic factor and its receptor GFRα1 induce Nurr1 and Pitx3 to promote survival of grafted midbrain-derived neural stem cells in a rat model of Parkinson disease. J Neuropathol Exp Neurol. 2011; 70(9):736-47. DOI: 10.1097/NEN.0b013e31822830e5. View

Battisti J, Uretsky N, Wallace L . Sensitization of apomorphine-induced stereotyped behavior in mice is context dependent. Psychopharmacology (Berl). 1999; 146(1):42-8. DOI: 10.1007/s002130051086. View

Dodson S, Bernard G, Kenney E, Carranza F . In vitro comparison of aged and young osteogenic and hemopoietic bone marrow stem cells and their derivative colonies. J Periodontol. 1996; 67(3):184-96. DOI: 10.1902/jop.1996.67.3.184. View

Kim J, Lee J, Im K, Kim S, Kim S, Lee D . Performance measurement of the microPET focus 120 scanner. J Nucl Med. 2007; 48(9):1527-35. DOI: 10.2967/jnumed.107.040550. View

Arthur A, Rychkov G, Shi S, Koblar S, Gronthos S . Adult human dental pulp stem cells differentiate toward functionally active neurons under appropriate environmental cues. Stem Cells. 2008; 26(7):1787-95. DOI: 10.1634/stemcells.2007-0979. View

Vollner F, Ernst W, Driemel O, Morsczeck C . A two-step strategy for neuronal differentiation in vitro of human dental follicle cells. Differentiation. 2009; 77(5):433-41. DOI: 10.1016/j.diff.2009.03.002. View

Ramos-Moreno T, Castillo C, Martinez-Serrano A . Long term behavioral effects of functional dopaminergic neurons generated from human neural stem cells in the rat 6-OH-DA Parkinson's disease model. Effects of the forced expression of BCL-X(L). Behav Brain Res. 2012; 232(1):225-32. DOI: 10.1016/j.bbr.2012.04.020. View

Fraix V, Pollak P, Van Blercom N, Xie J, Krack P, Koudsie A . Effect of subthalamic nucleus stimulation on levodopa-induced dyskinesia in Parkinson's disease. Neurology. 2001; 55(12):1921-3. DOI: 10.1212/wnl.55.12.1921. View

Huang A, Snyder B, Cheng P, Chan A . Putative dental pulp-derived stem/stromal cells promote proliferation and differentiation of endogenous neural cells in the hippocampus of mice. Stem Cells. 2008; 26(10):2654-63. PMC: 4416417. DOI: 10.1634/stemcells.2008-0285. View

10.

de la Fuente-Fernandez R, Schulzer M, Mak E, Calne D, Stoessl A . Presynaptic mechanisms of motor fluctuations in Parkinson's disease: a probabilistic model. Brain. 2004; 127(Pt 4):888-99. DOI: 10.1093/brain/awh102. View

11.

Hedlund E, Perlmann T . Neuronal cell replacement in Parkinson's disease. J Intern Med. 2009; 266(4):358-71. DOI: 10.1111/j.1365-2796.2009.02155.x. View

12.

Ratzka A, Kalve I, Ozer M, Nobre A, Wesemann M, Jungnickel J . The colayer method as an efficient way to genetically modify mesencephalic progenitor cells transplanted into 6-OHDA rat model of Parkinson's disease. Cell Transplant. 2011; 21(4):749-62. DOI: 10.3727/096368911X586774. View

13.

Paille V, Henry V, Lescaudron L, Brachet P, Damier P . Rat model of Parkinson's disease with bilateral motor abnormalities, reversible with levodopa, and dyskinesias. Mov Disord. 2007; 22(4):533-9. DOI: 10.1002/mds.21308. View

14.

Yoon H, Lee C, Hong S, Min J, Kim Y, Hwang O . Evaluation of a multiple system atrophy model in rats using multitracer microPET. Acta Neurochir (Wien). 2011; 154(5):935-40. DOI: 10.1007/s00701-011-1133-z. View

15.

Tsuji T, Hughes F, McCulloch C, Melcher A . Effects of donor age on osteogenic cells of rat bone marrow in vitro. Mech Ageing Dev. 1990; 51(2):121-32. DOI: 10.1016/0047-6374(90)90094-v. View

16.

Arthur A, Shi S, Zannettino A, Fujii N, Gronthos S, Koblar S . Implanted adult human dental pulp stem cells induce endogenous axon guidance. Stem Cells. 2009; 27(9):2229-37. DOI: 10.1002/stem.138. View

17.

Kim B, Bae H, Kwon I, Lee E, Park J, Khademhosseini A . Osteoblastic/cementoblastic and neural differentiation of dental stem cells and their applications to tissue engineering and regenerative medicine. Tissue Eng Part B Rev. 2012; 18(3):235-44. PMC: 3357080. DOI: 10.1089/ten.TEB.2011.0642. View

18.

Puschban Z, Scherfler C, Granata R, Laboyrie P, Quinn N, Jenner P . Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral.... Neuroscience. 2000; 95(2):377-88. DOI: 10.1016/s0306-4522(99)00457-1. View

19.

Kim S, Choi J, Chang J, Kim S, Hwang O . Immobilization stress causes increases in tetrahydrobiopterin, dopamine, and neuromelanin and oxidative damage in the nigrostriatal system. J Neurochem. 2005; 95(1):89-98. DOI: 10.1111/j.1471-4159.2005.03342.x. View

20.

Benabid A, Krack P, Benazzouz A, Limousin P, Koudsie A, Pollak P . Deep brain stimulation of the subthalamic nucleus for Parkinson's disease: methodologic aspects and clinical criteria. Neurology. 2001; 55(12 Suppl 6):S40-4. View